Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.48
Delayed Data
As of 4:02pm ET
 +0.36 / +0.88%
Today’s Change
37.20
Today|||52-Week Range
45.58
+7.71%
Year-to-Date

Today’s Trading

Previous close41.12
Today’s open41.44
Day’s range41.30 - 41.75
Volume3,488,967
Average volume (3 months)3,262,551
Market cap$101.1B
Dividend yield6.41%
Data as of 4:02pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+9.68%
Earnings growth (next 5 years)+8.67%
Revenue growth (last year)+2.85%
P/E ratio111.5
Price/Sales2.52
Price/Book72.05

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.44+0.68%
CELGCelgene+2.37+1.92%
LLYEli Lilly and Co-2.22-2.66%
----
Data as of 4:03pm ET, 04/25/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs